NuvOx Pharma’s NVX-208 Shows Positive Results in Phase Ib/II Stroke Trial
Positive results of NuvOx Pharma’s NVX-208 in the treatment of stroke have been published at the International Stroke Conference. The trial was sponsored by the University of Arkansas for Medical Sciences. William “Bill” Culp, MD, the principal investigator on the trial, said, “Such strong safety and promising efficacy results meet our highest hopes for this … Continue reading NuvOx Pharma’s NVX-208 Shows Positive Results in Phase Ib/II Stroke Trial
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed